Cargando…

Nanoparticles for the treatment of liver fibrosis

Chronic liver diseases represent a global health problem due to their high prevalence worldwide and the limited available curative treatment options. They can result from various causes, both infectious and noninfectious diseases. The application of nanoparticle (NP) systems has emerged as a rapidly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poilil Surendran, Suchithra, George Thomas, Reju, Moon, Myeong Ju, Jeong, Yong Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614791/ https://www.ncbi.nlm.nih.gov/pubmed/29033567 http://dx.doi.org/10.2147/IJN.S145951

Ejemplares similares

Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy
por: Thomas, Reju George, et al.
Publicado: (2020)

Corrigendum: Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy
por: Thomas, Reju George, et al.
Publicado: (2021)

Bioactive Nanoparticles for Cancer Immunotherapy
por: Poilil Surendran, Suchithra, et al.
Publicado: (2018)

Effect of hepato-toxins in the acceleration of hepatic fibrosis in hepatitis B mice
por: Poilil Surendran, Suchithra, et al.
Publicado: (2020)

Biomedical Applications of Hyaluronic Acid-Based Nanomaterials in Hyperthermic Cancer Therapy
por: Kim, Subin, et al.
Publicado: (2019)

Heptamethine Cyanine Dye MHI-148-Mediated Drug Delivery System to Enhance the Anticancer Efficiency of Paclitaxel
por: Raveendran, Athira, et al.
Publicado: (2021)

Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model
por: Thomas, Reju George, et al.
Publicado: (2015)

Near-Infrared Heptamethine Cyanine Based Iron Oxide Nanoparticles for Tumor Targeted Multimodal Imaging and Photothermal Therapy
por: Lee, Sejy, et al.
Publicado: (2017)

Magnetic Iron Oxide Nanoparticles for Multimodal Imaging and Therapy of Cancer
por: Thomas, Reju, et al.
Publicado: (2013)

Advances on the roles of tenascin-C in cancer
por: Yilmaz, Alev, et al.
Publicado: (2022)

NIRF Heptamethine Cyanine Dye Nanocomplexes for Multi Modal Theranosis of Tumors
por: Thomas, Reju George, et al.
Publicado: (2017)

Stimuli-Responsive Polymeric Nanomaterials for the Delivery of Immunotherapy Moieties: Antigens, Adjuvants and Agonists
por: Nagareddy, Raveena, et al.
Publicado: (2021)

Intravitreal Injection of Liposomes Loaded with a Histone Deacetylase Inhibitor Promotes Retinal Ganglion Cell Survival in a Mouse Model of Optic Nerve Crush
por: Sung, Mi Sun, et al.
Publicado: (2020)

Retraction: Radio frequency triggered curcumin delivery from thermo and pH responsive nanoparticles containing gold nanoparticles and its in vivo localization studies in an orthotopic breast tumor model
por: Rejinold, N. Sanoj, et al.
Publicado: (2020)

Biomedical Applications of Magnetically Functionalized Organic/Inorganic Hybrid Nanofibers
por: Lee, Hwa-Jeong, et al.
Publicado: (2015)

Magnetic-Assisted Treatment of Liver Fibrosis
por: Levada, Kateryna, et al.
Publicado: (2019)

Hyaluronic Acid-Based Nanomaterials for Cancer Therapy
por: Kim, Jin Hong, et al.
Publicado: (2018)

Treatment of liver fibrosis: Past, current, and future
por: Zhang, Chun-Ye, et al.
Publicado: (2023)

Risk of liver fibrosis in patients with prediabetes and diabetes mellitus
por: Park, Jongsin, et al.
Publicado: (2022)

Chinese medicines as a resource for liver fibrosis treatment
por: Feng, Yibin, et al.
Publicado: (2009)

Epigenetics and Liver Fibrosis
por: Moran-Salvador, Eva, et al.
Publicado: (2017)

Ferroptosis and Liver Fibrosis
por: Pan, Qi, et al.
Publicado: (2021)

Mesenchymal stem cell therapy for liver fibrosis
por: Eom, Young Woo, et al.
Publicado: (2015)

The Potential Application of Magnetic Nanoparticles for Liver Fibrosis Theranostics
por: Eftekhari, Aziz, et al.
Publicado: (2021)

Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis
por: An, Su Yeon, et al.
Publicado: (2021)

Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
por: Su, Tung-Hung, et al.
Publicado: (2014)

Current Treatment Options for Cystic Fibrosis-Related Liver Disease
por: Staufer, Katharina
Publicado: (2020)

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
por: Roehlen, Natascha, et al.
Publicado: (2020)

Treatment with 4-Methylpyrazole Modulated Stellate Cells and Natural Killer Cells and Ameliorated Liver Fibrosis in Mice
por: Yi, Hyon-Seung, et al.
Publicado: (2015)

Toll-Like Receptor Signaling and Liver Fibrosis
por: Aoyama, Tomonori, et al.
Publicado: (2010)

Multifunctional Nanocarpets for Cancer Theranostics: Remotely Controlled Graphene Nanoheaters for Thermo-Chemosensitisation and Magnetic Resonance Imaging
por: Ramachandra Kurup Sasikala, Arathyram, et al.
Publicado: (2016)

Coagulation, Microenvironment and Liver Fibrosis
por: Bitto, Niccolò, et al.
Publicado: (2018)

Metabolic Reprogramming of Liver Fibrosis
por: Delgado, M. Eugenia, et al.
Publicado: (2021)

Combatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis
por: Chen, Li, et al.
Publicado: (2018)

Dually Active Polycation/miRNA Nanoparticles for the Treatment of Fibrosis in Alcohol-Associated Liver Disease
por: Zhang, Chuhan, et al.
Publicado: (2022)

Significance of progressive liver fibrosis in pediatric liver transplants: A review of current evidence
por: George, Mathew, et al.
Publicado: (2020)

Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosis
por: Wang, Min, et al.
Publicado: (2020)

Recent research trends and updates on nonalcoholic fatty liver disease
por: Yoo, Jeong-Ju, et al.
Publicado: (2019)

Genomics and proteomics in liver fibrosis and cirrhosis
por: Hannivoort, Rebekka A, et al.
Publicado: (2012)

Molecular Serum Markers of Liver Fibrosis
por: Liu, Tianhui, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_40ktjq67knde16g0bmteji7ru7